Abstract
Apoptosis is one of the fundamental phenomena behind successful radiation and chemotherapy treatments. Non-invasive imaging of apoptosis can offer an early diagnosis of disease and the true efficiency of an ongoing treatment procedure. The present study describes an attempt to develop 99mTc-labeled 2-methyl-2-pentylmalonic acid ([99mTc] 8) as a new SPECT based apoptosis imaging agent. An optimized chemical and radiosynthesis procedure provided desired product [99mTc] 8 with high radiochemical yield (84%, n = 3) and radiochemical purity (>99%) as determined by radio HPLC. Biodistribution data indicated that the radiotracer has a rapid clearance from blood and other background tissues. High testes accumulation confirmed the ability of the radiotracer to detect testicular apoptosis in mice.
Original language | English |
---|---|
Pages (from-to) | 207-215 |
Number of pages | 9 |
Journal | Journal of Radioanalytical and Nuclear Chemistry |
Volume | 313 |
Issue number | 1 |
DOIs | |
State | Published - 1 Jul 2017 |
Keywords
- Tc-labeling
- Apoptosis
- Biodistribution
- SPECT imaging